The spectrum of endometrial pathology induced by progesterone receptor modulators
- 1 May 2008
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 21 (5), 591-598
- https://doi.org/10.1038/modpathol.2008.19
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Progesterone receptor modulators and the endometrium: changes and consequences†Human Reproduction Update, 2007
- Benign Endometrial Hyperplasia Sequence and Endometrial Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 2007
- Twelve-month safety and efficacy of low-dose mifepristone for uterine myomasJournal of Minimally Invasive Gynecology, 2005
- Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applicationsHuman Reproduction Update, 2005
- Discovery, Chemistry, and Reproductive Pharmacology of Asoprisnil and Related 11β-Benzaldoxime Substituted Selective Progesterone Receptor Modulators (SPRMs)Seminars in Reproductive Medicine, 2005
- Mifepristone: a novel estrogen-free daily contraceptive pillSteroids, 2003
- Daily Low-Dose Mifepristone Has Contraceptive Potential by Suppressing Ovulation and Menstruation: A Double-Blind Randomized Control Trial of 2 and 5 mg per Day for 120 DaysJournal of Clinical Endocrinology & Metabolism, 2002
- Progesterone Antagonists Increase Androgen Receptor Expression in the Rhesus Macaque and Human EndometriumJournal of Clinical Endocrinology & Metabolism, 2001
- The epidemiology of endometrial cancerGynecologic Oncology, 1991
- Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated EstrogensNew England Journal of Medicine, 1985